Lv61
1606 积分 2025-06-24 加入
97 PREGNANCY OUTCOMES IN WOMEN WITH INFLAMMATORY BOWEL DISEASE EXPOSED TO TOFACITINIB, OZANIMOD, OR UPADACITINIB: A MULTICENTER REAL-WORLD COHORT ANALYSIS USING A FEDERATED ELECTRONIC HEALTH RECORD NETWORK
2小时前
求助中
Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial
2个月前
已完结
Contact allergy to tetrahydrocurcumin
3个月前
已完结
Tetrahydracurcumin-related allergic contact dermatitis
3个月前
已完结
Chapter 8 - Safety and regulatory considerations
3个月前
已关闭
Chapter 8 - Safety and regulatory considerations
3个月前
已关闭
Promising Potential of Curcumin and Related Compounds for Antiviral Drug Discovery
3个月前
已完结
The role of tetrahydrocurcumin in disease prevention and treatment
3个月前
已完结
慢性便秘检查与评估中国专家共识（2024版）
4个月前
已完结
慢性便秘检查与评估中国专家共识（2024版）
4个月前
已关闭
皖公网安备34019202002308
